Guided Therapeutics (GTHP) Notes Payables (2011 - 2026)
Guided Therapeutics (GTHP) posted Notes Payables of $347000.0 for Q4 2025, up 139.31% sequentially from $145000.0 in Q3 2025, and up 149.64% YoY from $139000.0 in Q4 2024.
Guided Therapeutics (GTHP) Notes Payables (2011 - 2026) Analysis & Trends
Guided Therapeutics has reported Notes Payables for 15 years, with the latest figure at $347000.0 in Q4 2025.
- Quarterly Notes Payables rose 149.64% year-over-year to $347000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $347000.0 (up 149.64% YoY) and the FY2025 annual result came in at $347000.0, up 149.64% from the prior year.
- Notes Payables rose to $347000.0 in Q4 2025 per GTHP's latest filing, from $145000.0 in the prior quarter.
- Over five years, Notes Payables peaked at $579000.0 in Q3 2022 and troughed at $23000.0 in Q1 2023.
- A 5-year average of $131882.4 and a median of $94000.0 in 2023 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2021 and 2023: Notes Payables soared 6400.0% in 2021, then tumbled 83.77% in 2023.
- Over 5 years, Notes Payables stood at $161000.0 in 2021, then sank by 64.6% to $57000.0 in 2022, then surged by 64.91% to $94000.0 in 2023, then jumped by 47.87% to $139000.0 in 2024, then jumped by 149.64% to $347000.0 in 2025.
- According to Business Quant data, Notes Payables over the past three periods registered $347000.0, $145000.0, and $24000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 296,000.00 |
| Dec 31, 2025 | 347,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 48,000.00 |
| Dec 31, 2024 | 139,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Sep 30, 2023 | 94,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 57,000.00 |
| Sep 30, 2022 | 579,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 161,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Mar 31, 2021 | 137,000.00 |
| Sep 30, 2020 | 116,000.00 |
| Jun 30, 2020 | 1,000.00 |